日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Spatial omics study reveals molecular-cellular dynamics of tumor ecosystem in esophageal squamous-cell carcinoma initiation and progression.

空间组学研究揭示了食管鳞状细胞癌发生发展过程中肿瘤生态系统的分子细胞动力学。

期刊:Cell Reports Medicine
影响因子:10.6
doi:10.1016/j.xcrm.2026.102650
Liu Zhao, Zhou Wenhao, Li Lei, Song Congcong, Yue Meng, Lv Huilai, Li Zhenhua, Zhang Minghao, Li Na, Wang Jiaqian, Zhao Lianmei, Luo Haitao, Tian Ziqiang
细胞生物学
发表日期：2026
文献求助 收藏

HSPA5 promotes YAP/TAZ stability independently of the Hippo pathway and induces proneural-to-mesenchymal transition in glioblastoma.

HSPA5 促进 YAP/TAZ 的稳定性，且不依赖于 Hippo 通路，并诱导胶质母细胞瘤发生神经向间质转化。

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/s41419-026-08428-3
Gui Shikai, Yu Wanli, Song Zhen, Peng Lunshan, Luo Haitao, Huang Kai, Xiao Juexian, Xie Jiabao, Cai Shihao, Yuan Shengtao, Tao Zhennan, Cheng Zujue
信号转导
YAP
细胞生物学
TAZ
Hippo
发表日期：2026
文献求助 收藏

Spatial molecular analyses reveal key features associated with response to KN026 in advanced HER2-positive breast cancer

空间分子分析揭示了与晚期 HER2 阳性乳腺癌对 KN026 治疗反应相关的关键特征

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-025-03287-9
Ma, Jianli; Sun, Shengnan; Tang, Xiaowen; Wang, Jingxuan; Zhao, Wenhui; Tang, Dabei; Song, Ying; Li, Liru; Luo, Haitao; Liu, Xuhui; Deng, Yuwei; Zhang, Qingyuan
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Tislelizumab (anti-PD-1) plus chemotherapy as neoadjuvant therapy for patients with stage IB3/IIA2 cervical cancer (NATIC): a prospective, single-arm, phase II study

替雷利珠单抗（抗PD-1）联合化疗作为IB3/IIA2期宫颈癌患者的新辅助治疗（NATIC）：一项前瞻性、单臂、II期研究

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02294-9
Sheng, Jindong; Luo, Haitao; Liu, Xiangyu; Liu, Chunyan; Zhou, Wenhao; Zhao, Yujie; Liu, Ruoyan; Li, Dan; Xu, Changxiao; Yang, Bo; Liu, Ying; Fu, Xin; Bao, Lewen; Wang, Ke; Hao, Jihui; Liu, Wenxin
宫颈癌
肿瘤
肿瘤免疫
PD-1
发表日期：2025
文献求助 收藏

Liquid biopsy using plasma proteomics in predicting efficacy and tolerance of PD-1/PD-L1 blockades in NSCLC: a prospective exploratory study

利用血浆蛋白质组学进行液体活检预测非小细胞肺癌患者对PD-1/PD-L1阻断疗法的疗效和耐受性：一项前瞻性探索性研究

期刊:Molecular Biomedicine
影响因子:10.1
doi:10.1186/s43556-025-00291-6
Gao, Yuan; Qi, Fei; Zhou, Wenhao; Jiang, Peng; Hu, Mingming; Wang, Ying; Song, Congcong; Han, Yi; Li, Dongdong; Qin, Na; Zhang, Hongmei; Luo, Haitao; Zhang, Tongmei; Li, Hongxia
肺癌
肿瘤
肿瘤免疫
PD-L1
细胞生物学
PD-1
发表日期：2025
文献求助 收藏

Serial monitoring of cerebrospinal fluid in patients with leptomeningeal metastases in lung cancer via the Ommaya reservoir as a predictive indicator of therapeutic efficacy and clinical prognosis

通过 Ommaya 储液器对肺癌软脑膜转移患者的脑脊液进行连续监测，作为治疗效果和临床预后的预测指标

期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-025-01218-8
Fang, Hehui; Luo, Haitao; Li, Shujin; Yan, Naimeng; Xu, Shu; Liu, Na; Wang, Xiaoyue; Xu, Ting; Cheng, Wanwan; Liu, Yong; Yu, Chuanyong; Fang, Shencun
肺癌
肿瘤
肿瘤免疫
神经科学
发表日期：2025
文献求助 收藏

CIEC: Cross-tissue Immune Cell Type Enrichment and Expression Map Visualization for Cancer

CIEC：癌症跨组织免疫细胞类型富集和表达图谱可视化

期刊:Genomics Proteomics & Bioinformatics
影响因子:7.9
doi:10.1093/gpbjnl/qzae067
He, Jinhua; Luo, Haitao (罗海涛); Wang, Wei (王伟); Bu, Dechao (卜德超); Zou, Zhengkai (邹正楷); Wang, Haolin (王浩霖); Tang, Hongzhen; Han, Zeping; Luo, Wenfeng; Shen, Jian; Xie, Fangmei; Zhao, Yi (赵屹); Xiang, Zhiming
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Spatial transcriptomic analysis across histological subtypes reveals molecular heterogeneity and prognostic markers in early-stage lung adenocarcinoma.

跨组织学亚型的空间转录组分析揭示了早期肺腺癌的分子异质性和预后标志物

期刊:Clinical and Translational Medicine
影响因子:6.8
doi:10.1002/ctm2.70439
Geng Hua, Zhou Wenhao, Luo Haitao, Wang Jiaqian, Li Shixiong, Song Congcong, Zhao Yujie, Xu Meilin
肿瘤
肺癌
发表日期：2025
文献求助 收藏

TMEM71 is crucial for cell proliferation in lower-grade glioma and is linked to unfavorable prognosis.

TMEM71 对低级别胶质瘤的细胞增殖至关重要，并且与不良预后相关

期刊:Cancer Cell International
影响因子:6
doi:10.1186/s12935-025-03747-5
Xie Jiabao, Yu Wanli, Gui Shikai, Peng Lunshan, Xiao Juexian, Luo Haitao, Cheng Zujue
细胞生物学
发表日期：2025
文献求助 收藏

SLC4A7 suppresses lung adenocarcinoma oncogenesis by reducing lactate transport and protein lactylation.

SLC4A7 通过减少乳酸转运和蛋白质乳酸化来抑制肺腺癌的发生

期刊:International Journal of Oncology
影响因子:4.9
doi:10.3892/ijo.2025.5739
Yan Haojie, He Qian, Gao Yubiao, He Xiaomei, Luo Haitao, Shao Lijuan, Dong Jun, Li Furong
肿瘤
肺癌
发表日期：2025
文献求助 收藏